Hepatitis B virus-associated glomerulonephritis in adults

Nephrology

Volumn 2, Issue SUPPL. 1, 1996, Pages s72-s79

  Lai, Kar Neng ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Glomerulonephritis; Hepatitis B virus; IgA nephropathy; Interferon; Membranous nephropathy; Mesangiocapillary glomerulonephritis

Indexed keywords

EID: 1842484503     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1996.tb00145.x     Document Type: Article

References (55)

1. Will H, Cattaneo R, Koch HG et al. Cloned HBN DNA causes hepatitis B in chimpanzees. Nature 1982; 299: 740-2.
2. Robinson WS, Marion PL, Miller RH. The hepadna viruses of animals. Semin. Liver Dis. 1984; 4: 347-60.
3. Szmuness W, Harley EJ, Ikram H, Stevens CE. Sociodemographic aspects of the epidemiology of hepatitis B. In: Vyas GN, Cohen SN, Schmid R (eds). Viral Hepatitis. Franklin Institute, Philadelphia, 1978; 297-320.
4. Wong V, Ip H, Reesink H et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis B vaccine and hepatitis B immunogloublin. Lancet 1984; 1: 921-6.
5. Combes B, Stastny P, Shorey J et al. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet 1971; 2: 234-7.
6. Maggiore Q, Bartolomeo F, L'Abbate A, Misefari V. HBsAg glomerular deposits in glomerulonephritts: Fact or artifacts? Kidney Int. 1981; 19: 579-86,
7. Takekoshi Y, Tanaka M, Shida N et al. Strong association between membranous nephropathy and hepatitis-B surface antigenemia in Japanese children. Lancet 1978; 2: 1065-8.
8. Nagy J, Bajtai G, Brasch H et al. The role of hepatis B surface antigen in the pathogenesis of glomerulonephritis. Clin. Nephrol. 1979; 12: 109-16.
9. Lai KN, Lai FM, Chan KW et al. The clinico-pathological features of hepatitis B virus associated glomerulonephritis. Q.J. Med. 1987; 63: 323-33.
10. Gyorkey F, Hollinger F, Eknoyan G et al. Immune-complex glomerulonephritis, intra-nuclear particles in hepatocytes, and in vivo clearance rates in sub-human primates inoculated with HBsAg-containing plasma. Exp. Mol. Pathol. 1975; 22: 350-65.
11. Germuth FG, Senterfit LB, Dreesman GR. Immune complex disease V. The nature of the chronic HSA-rabbit system. Johns Hopkins Med. J. 1972; 130: 814-19.
12. Peters DN, Steinberg H, Anderson WI et al. Immunopathology of IgA glomerulonephritis associated with chronic woodchuck hepatitis virus infection in woodchucks. Am. J. Pathol. 1992; 141: 143-52.
13. Brzoko W, Krawczynski K, Nazarewicz T et al. Glomerulonephritis assiciated with hepatitis B surface antigen immune complexes in children. Lancet 1974; 2: 476-82.
14. Hsu HC, Lin GH, Chang MH et al. Association of hepatitis B surface antigenemia and membranous nephropathy in children in Taiwan. Clin. Nephrol. 1983; 20: 121-9.
15. Sluzarczk J, Michalak T, Nazarewicz-de Mezer T et al. Membranous glomerulopathy associated with hepatitits B core antigen immune complexes in children. Am. J. Pathol. 1980; 98: 29-39.
16. Venkatasseshan VS, Lieberman K, Kim DU et al. Hepatits-B-associated glomerulonephritis: Pathology, pathogenesis, and clinical course. Medicine 1990; 69: 200-16.
17. Amemiya S, Ito H, Kato K et al. A case of membranous proliferative glomerulonephritis type III (Burkholder) with the deposition of both HBsAg and HBeAg. Int. J. Pediatr. Nephrol. 1983; 4: 267-73.
18. Lai KN, Lai FM, Lo S et al. IgA nephropathy associated with hepatitis B virus antigenemia. Nephron 1987; 47: 341-3.
19. Lai KN, Lai FM, Tam JS. IgA nephropathy associated with chronic hepatitis B virus infection in adults. The pathogenetic role of HBsAg. J. Pathol. 1989; 157: 321-7.
20. Takeda S, Kida H, Katagiri M et al. Characteristics of glomerular lesions in hepatitis B virus infection. Am. J. Kidney Dis. 1988; 11: 57-62.
21. Lai KN, Lai FM, Tam JS et al. High prevalence of hepatitis B surface antigenemia in nephrotic syndrome in Hong Kong. Ann. Trop. Paediatr. 1989; 9: 45-8.
22. Looi LM, Prathap K. Hepatitis B virus surface antigen in glomerular immune complex deposits of patients with systemic lupus erythematosus. Histopathology 1982; 6: 141-7.
23. Lai KN, Lai FM, Leung A, Lo S. Is there a pathogenetic role of hepatitis B virus in lupus nephritis? Arch. Pathol. Lab. Med. 1987; 111: 185-8.
24. Editorial. HBV and glomerulonephritis. Lancet 1987; 2: 252-3.
25. Lai KN, Lai FM, Lo S, Lam CWK. IgA nephropathy and membranous nephropathy associated with hepatitis B surface antigenemia. Hum. Pathol. 1987; 18: 411-14.
26. Hirose H, Udo K, Kojima M et al. Deposition of hepatitis B e antigen in membranous glomerulonephritis. Kidney Int. 1984; 26: 338-41.
27. Ito H, Hattori S, Matusda I et al. Hepatitis B e antigen-mediated membranous glomerulonephritis. Lab. Invest. 1981; 44: 214-20.
28. Lai KN, Lai FM, Tam JS. Comparison of polyclonal and monoclonal antibodies in determination of glomerular deposits of hepatitis B virus antigens in hepatitis B virus associated glomerulonephritis. Am. J. Clin. Pathol. 1989; 92: 159-65.
29. Sham MK, Pun KK, Yeung CK et al. Hepatitis B induced glomerulonephritis, fact or fiction. Aust. N. Z. J. Med. 1985; 15: 256-8.
30. Collins AB, Bhan AK, Dienstag JL et al. Hepatitis B immune complex glomerulonephritis: Simultaneous glomerular deposition of hepatitis B surface and e antigens. Clin. Immunol. Immunopathol. 1983; 26: 137-53.
31. Magil A, Webber D, Chan V. Glomerulonephritits associated with hepatitis B surface antigenemia: Report of a case with features of both membranous and IgA nephropathy. Nephron 1986; 42: 335-9.
32. Furuse A, Hattori S, Terashima T et al. Circulating immune complexes in glomerulopathy associated with hepatitis B virus infection. Nephron 1982; 31: 212-18.
33. Peeples ME, Komai K, Radek R, Bankowski MJ. A cultured cell receptor for the small S protein of hepatitis B virus. Virology 1987; 160: 135-11.
34. Lai FM, Tam JS, Li P, Lai KN. Replication of hepatitis B virus with corticosteroid therapy in hepatitis B virus related membranous nephropathy. Virchows Arch. Pathol. Anat. 1989; 414: 279-98.
35. Lai FM, Lai KN, Tam JS. Detection of hepatitis B virus DNA in kidney of patients with HBV associated glomerulonephritis. In: Davison AM (ed.) Abstracts of the Tenth International Congress of Nephrology, London, The Alder Press, Oxford, 1987; 388.
36. Lai KN, Lai FM, Tam JS, Vallance-Owen J. Strong association between IgA nephropathy and hepatitis B surface antigenemia in endemic area. Clin. Nephrol. 1988; 29: 229-34.
37. Korba BE, Brown JL, Wells RV et al. Natural history of experimental WHV infection: Molecular virologie features of the pancreas, kidney, ovary and testis. J. Virol. 1990; 60: 4499-506.
38. Lin CY. Hepatitis B virus DNA in kidney cells probably leading to viral pathogenesis among hepatitis B virus associated membranous nepthopathy patients. Nephron 1993; 63: 58-64.
39. Halpern MS, England JM, Deery DT, Peteu DJ, Mason WS, Molnar-Kimber KL. Viral nucleic acid synthesis and antigen accumulation in pancreas and kidney of Pekin ducks infected with duck hepatitis B virus. Proc. Natl Acad. Sci. USA 1983; 80: 4865-69.
40. Farza H, Hadchouel M, Scotto J, Tiollais P, Babinet C, Pourcel C. Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome. J. Virol. 1988; 62: 4144-52.
41. Araki K, Miyazaki JI, Hino O et al. Expression and replication of hepatitis B virus genome in transgenic mice. Proc. Natl Acad. Sci. USA 1989; 86: 207-11.
42. Lai KN, Tam JS, Lin HJ, Lai FM. The therapeutic dilemma of usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenemia. Nephron 1990; 54: 12-17.
43. Kleinknecht C, Levy M, Peix A et al. Membranous glomerulonephritis and hepatitis B surface antigen in children. J. Pediatr. 1979; 95: 946-52.
44. Kohler PF, Chromin RE, Hammond WS et al. Chronic membranous glomerulonephritis caused by hepatitis antigen-antibody immune complexes. Ann. Intern. Med. 1974; 81: 448-51.
45. Lai KN, Li PKT, Lui SF et al. Membranous nephropathy related to hepatitis B virus in adults. N. Engl. J. Med. 1991; 324: 1457-63.
46. Knecht GL, Chisari FV. Reversibility of hepatitis B virus-induced glomerulonephritis and chronic active hepatitis after spontaneous clearance of serum hepatitis B surface antigen. Gastroenterology 1978; 75: 1152-6.
47. Cadrobbi P, Bortolotti F, Zacchello G et al. Hepatitis B virus replication in acute glomerulonephritis with chronic active hepatitis. Arch. Dis. Child. 1985; 60: 583-5.
48. Hoofnagle JH, Davis MD, Pappas C et al. A short course of prednisolone in chronic type B hepatitis. Ann. Intern. Med. 1986; 104: 12-17.
49. Lin CY, Lo S. Treatment of hepatitis B virus-associated membranous nephropathy with adenine arabinoside and thymic extract. Kidney Int. 1991; 39: 301-6.
50. Garcia G, Scullard G, Smith C et al. Preliminary observation of hepatitis B-associated membranous glomerulonephritis treated with leukocyte interferon. Hepatology 1985; 5: 317-20.
51. Mizushima N, Kanai K, Matsuda H et al. Improvement of proteinuria in a case of hepatitis B-associated glomerulonephritis after treatment with interferon. Gastroenterology 1987; 92: 524-6.
52. Lisker-Melman M, Webb D, Di Bisceglie et al. Glomerulonephritis caused by hepatitis B virus infection: Treatment with recombinant human α-interferon. Ann. Intern. Med. 1989; 111: 479-83.
53. Lai CL, Lok AS, Lin HJ et al. Placebo-controlled trial of recombinant α 2-interferon in Chinese HBsAg carrier children. Lancet 1987; 2: 877-80.
54. Lin CY. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int. 1995; 47: 225-30.
55. Conjeevarum HS, Hoofnagle JH, Austin HA, Park Y, Fried MW, Di Bisceglie AM. Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with Interferon Alfa. Gastroenterology 1995; 109: 540-6.